Related references
Note: Only part of the references are listed.ARTIFICIAL CELL evolves into nanomedicine, biotherapeutics, blood substitutes, drug delivery, enzyme/gene therapy, cancer therapy, cell/stem cell therapy, nanoparticles, liposomes, bioencapsulation, replicating synthetic cells, cell encapsulation/scaffold, biosorbent/immunosorbent haemoperfusion/plasmapheresis, regenerative medicine, encapsulated microbe, nanobiotechnology, nanotechnology
Thomas Ming Swi Chang
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Carboplatin prodrug conjugated Fe3O4 nanoparticles for magnetically targeted drug delivery in ovarian cancer cells
Haiqin Song et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Development and evaluation of novel tumor-targeting paclitaxel-loaded nano-carriers for ovarian cancer treatment: in vitro and in vivo
Shu Yao et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity
Hadi Zare-Zardini et al.
SCIENTIFIC REPORTS (2018)
In vitro and in vivo evaluation of folate receptor-targeted a novel magnetic drug delivery system for ovarian cancer therapy
Guliz Ak et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes
Sophieke C. H. A. van der Steen et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis
Jingxin Mo et al.
NANOSCALE (2017)
Tumor-targeting templated silica nanoparticles as a dual-drug delivery system for anti-angiogenic ovarian cancer therapy
Tianying Zheng et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Possible role of nanocarriers in drug delivery against cervical cancer
Swati Gupta et al.
NANO REVIEWS & EXPERIMENTS (2017)
Dendrimer nanoarchitectures for cancer diagnosis and anticancer drug delivery
Ashok Kumar Sharma et al.
DRUG DISCOVERY TODAY (2017)
Folate Receptor Targeted Delivery of siRNA and Paclitaxel to Ovarian Cancer Cells via Folate Conjugated Triblock Copolymer to Overcome TLR4 Driven Chemotherapy Resistance
Steven K. Jones et al.
BIOMACROMOLECULES (2016)
Ovarian cancer targeted hyaluronic acid-based nanoparticle system for paclitaxel delivery to overcome drug resistance
Liping Wang et al.
DRUG DELIVERY (2016)
Antitumor effects of cecropin B-LHRH' on drug-resistant ovarian and endometrial cancer cells
Xiaoyong Li et al.
BMC CANCER (2016)
Recent advances in polymeric micelles for anti-cancer drug delivery
Swati Biswas et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2016)
Intraperitoneal chemotherapy of ovarian cancer by hydrogel depot of paclitaxel nanocrystals
Bo Sun et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Precision targeted therapy of ovarian cancer
Justin Sapiezynski et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Biocompatible Targeting Hydrogels for Breast Cancer Treatment
R. Cassano et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2016)
Cyclic RGDfK Peptide Functionalized Polymeric Nanocarriers for Targeting Gemcitabine to Ovarian Cancer Cells
Hitesh Kulhari et al.
MOLECULAR PHARMACEUTICS (2016)
Formulation development of a novel targeted theranostic nanoemulsion of docetaxel to overcome multidrug resistance in ovarian cancer
Srinivas Ganta et al.
DRUG DELIVERY (2016)
Targeting the folate receptor: diagnostic and therapeutic approaches to personalize cancer treatments
J. A. Ledermann et al.
ANNALS OF ONCOLOGY (2015)
Telodendrimer nanocarrier for co-delivery of paclitaxel and cisplatin: A synergistic combination nanotherapy for ovarian cancer treatment
Liqiong Cai et al.
BIOMATERIALS (2015)
Polymer-Drug Conjugates for Anticancer Drug Delivery
Saurabh Wadhwa et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2015)
Follicle-Stimulating Hormone Receptor as a Target in the Redirected T-cell Therapy for Cancer
Katarzyna Urbanska et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Development and in vitro characterization of docetaxel-loaded ligand appended solid fat nanoemulsions for potential use in breast cancer therapy
Sachin Yadav et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2015)
Poly(styrene-alt-maleic anhydride)-Based Diblock Copolymer Micelles Exhibit Versatile Hydrophobic Drug Loading, Drug-Dependent Release, and Internalization by Multidrug Resistant Ovarian Cancer Cells
Michael P. Baranello et al.
BIOMACROMOLECULES (2014)
Efficient siRNA delivery and tumor accumulation mediated by ionically cross-linked folic acid-poly(ethylene glycol)-chitosan oligosaccharide lactate nanoparticles: For the potential targeted ovarian cancer gene therapy
Tony Shing Chau Li et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)
Follicle-stimulating hormone polypeptide modified nanoparticle drug delivery system in the treatment of lymphatic metastasis during ovarian carcinoma therapy
Lingling Fan et al.
GYNECOLOGIC ONCOLOGY (2014)
Targeted Transferrin-Modified Polymeric Micelles: Enhanced Efficacy in Vitro and in Vivo in Ovarian Carcinoma
Rupa R. Sawant et al.
MOLECULAR PHARMACEUTICS (2014)
Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells
Dimple A. Modi et al.
NANOSCALE (2014)
Paclitaxel-PHBV nanoparticles and their toxicity to endometrial and primary ovarian cancer cells
Cristian Vilos et al.
BIOMATERIALS (2013)
Nanocarriers for the targeted treatment of ovarian cancers
Julie Tomasina et al.
BIOMATERIALS (2013)
Liposome co-encapsulation of synergistic combination of irinotecan and doxorubicin for the treatment of intraperitoneally grown ovarian tumor xenograft
Ishaque M. Shaikh et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Poly(ethylene glycol)-block-poly(ε-caprolactone) micelles for combination drug delivery: Evaluation of paclitaxel, cyclopamine and gossypol in intraperitoneal xenograft models of ovarian cancer
Hyunah Cho et al.
JOURNAL OF CONTROLLED RELEASE (2013)
LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer
Natalia V. Nukolova et al.
MOLECULAR PHARMACEUTICS (2013)
Anti-KDEL-coated nanoparticles: A promising tumor targeting approach for ovarian cancer?
Florence Delie et al.
BIOCHIMIE (2012)
The potential role of anibamine, a natural product CCR5 antagonist, and its analogues as leads toward development of anti-ovarian cancer agents
Yan Zhang et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Emerging Role of Vesicular Carriers for Therapy of Visceral Leishmaniasis: Conventional versus Novel
Navneet Kumar et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Possible Role of Epidermal Growth Factor Receptors in the Therapy of Pancreatic Cancer
Sahil Aggarwal et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Colloidal Carriers: A Rising Tool for Therapy of Tuberculosis
Swati Gupta et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2012)
Patterns of first recurrence following adjuvant intraperitoneal chemotherapy for stage IIIC ovarian cancer
Edward J. Tanner et al.
GYNECOLOGIC ONCOLOGY (2012)
Inhibition of cell growth and induction of apoptosis in ovarian carcinoma cell lines CaOV3 and SKOV3 by natural withanolide Withaferin A
Xuan Zhang et al.
GYNECOLOGIC ONCOLOGY (2012)
Accumulation and toxicity of antibody-targeted doxorubicin-loaded PEG-PE micelles in ovarian cancer cell spheroid model
Federico Perche et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Hyaluronic acid-based hydrogel for regional delivery of paclitaxel to intraperitoneal tumors
Gaurav Bajaj et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Lapatinib/Paclitaxel polyelectrolyte nanocapsules for overcoming multidrug resistance in ovarian cancer
Daniele Vergara et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
Jonathan Ledermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Antiproliferation effect of Rosemary (Rosmarinus officinalis) on human ovarian cancer cells in vitro
Joseph Tai et al.
PHYTOMEDICINE (2012)
Drug Delivery Using Nanocarriers: Indian Perspective
Swati Gupta et al.
Proceedings of the National Academy of Sciences, India. Section B (2012)
The EPR effect: Unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect
Jun Fang et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study
J. E. Kurtz et al.
ANNALS OF ONCOLOGY (2011)
Folate-decorated nanogels for targeted therapy of ovarian cancer
Natalia V. Nukolova et al.
BIOMATERIALS (2011)
Multifunctional polyglycerol-grafted Fe3O4@SiO2 nanoparticles for targeting ovarian cancer cells
Liang Wang et al.
BIOMATERIALS (2011)
Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo
Yuxing Zhang et al.
CANCER LETTERS (2011)
Effect of kenaf seed oil from different ways of extraction towards ovarian cancer cells
Latifah Saiful Yazan et al.
FOOD AND BIOPRODUCTS PROCESSING (2011)
Antiproliferative activity of a phenolic extract from a native Chilean Amaranthaceae plant in drug-resistant ovarian cancer cell lines
J. Brouwer-Visser et al.
GYNECOLOGIC ONCOLOGY (2011)
A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study
Mark A. Morgan et al.
GYNECOLOGIC ONCOLOGY (2011)
A nomogram for estimating the probability of ovarian cancer
Jason A. Lachance et al.
GYNECOLOGIC ONCOLOGY (2011)
Intraperitoneal administration of novel doxorubicin loaded polymeric delivery systems against peritoneal carcinomatosis: Experimental study in a murine model of ovarian cancer
Pierre-Emmanuel Colombo et al.
GYNECOLOGIC ONCOLOGY (2011)
Novel nanotechnology approaches to diagnosis and therapy of ovarian cancer
Paul S. Kim et al.
GYNECOLOGIC ONCOLOGY (2011)
Evaluation of Folate-targeted ChemoRad Nanoparticle as Intraperitoneal Chemoradiotherapy for Ovarian Cancer
M. E. Werner et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2011)
Effect of Screening on Ovarian Cancer Mortality The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial
Saundra S. Buys et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Development and Characterization of Doxorubicin Loaded Microparticles Against Experimental Visceral Leishmaniasis
Sheeshpal Sharma et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2011)
EGFR Targeted PLGA Nanoparticles Using Gemcitabine for Treatment of Pancreatic Cancer
Sahil Aggarwal et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2011)
Evaluation of anionic half generation 3.5-6.5 poly(amidoamine) dendrimers as delivery vehicles for the active component of the anticancer drug cisplatin
Gordon J. Kirkpatrick et al.
JOURNAL OF INORGANIC BIOCHEMISTRY (2011)
Randomized Phase III Clinical Trial Evaluating Weekly Cisplatin for Advanced Epithelial Ovarian Cancer
Robert Fruscio et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Long-Term Survival of Women With Epithelial Ovarian Cancer Detected by Ultrasonographic Screening
John Rensselaer van Nagell et al.
OBSTETRICS AND GYNECOLOGY (2011)
Histologic, Molecular, and Cytogenetic Features of Ovarian Cancers: Implications for Diagnosis and Treatment
Neeraj Lalwani et al.
RADIOGRAPHICS (2011)
Polymer-Cisplatin Conjugate Nanoparticles for Acid-Responsive Drug Delivery
Santosh Aryal et al.
ACS NANO (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Preclinical efficacy studies of a novel nanoparticle-based formulation of paclitaxel that out-performs Abraxane
Zhongling Feng et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Current clinical use of biomarkers for epithelial ovarian cancer
Richard G. Moore et al.
CURRENT OPINION IN ONCOLOGY (2010)
Drug delivery strategies for therapy of visceral leishmaniasis
Swati Gupta et al.
EXPERT OPINION ON DRUG DELIVERY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Overcoming cisplatin resistance of ovarian cancer cells by targeted liposomes in vitro
Michaela L. Krieger et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
Benefit of anti-HER2-coated paclitaxel-loaded immuno-nanoparticles in the treatment of disseminated ovarian cancer: Therapeutic efficacy and biodistribution in mice
A. Cirstoiu-Hapca et al.
JOURNAL OF CONTROLLED RELEASE (2010)
Inhibition of human ovarian cancer cell lines by Devil's club Oplopanax horridus
Joseph Tai et al.
JOURNAL OF ETHNOPHARMACOLOGY (2010)
Curcumin induces chemo/radio-sensitization in ovarian cancer cells and curcumin nanoparticles inhibit ovarian cancer cell growth
Murali M. Yallapu et al.
JOURNAL OF OVARIAN RESEARCH (2010)
Targeting the EGF Receptor for Ovarian Cancer Therapy
Reema Zeineldin et al.
JOURNAL OF ONCOLOGY (2010)
Clinical trials and progress with paclitaxel in ovarian cancer
Sanjeev Kumar et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2010)
Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer
Zhenbo Zhang et al.
CANCER LETTERS (2009)
Follicle-Stimulating Hormone Peptide Can Facilitate Paclitaxel Nanoparticles to Target Ovarian Carcinoma In vivo
Xiao-yan Zhang et al.
CANCER RESEARCH (2009)
Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
H. Maeda et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Polymer micelles with cross-linked polyanion core for delivery of a cationic drug doxorubicin
Jong Oh Kim et al.
JOURNAL OF CONTROLLED RELEASE (2009)
FePt Nanoparticles as an Fe Reservoir for Controlled Fe Release and Tumor Inhibition
Chenjie Xu et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2009)
Dose-dense paclitaxel once a week in combination with carboplatin every 3 weeks for advanced ovarian cancer: a phase 3, open-label, randomised controlled trial
Noriyuki Katsumata et al.
LANCET (2009)
Screening for Ovarian Cancer
Daniel L. Clarke-Pearson
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer
Yogeshkumar Malam et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2009)
Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role
C. William Helm et al.
JOURNAL OF OVARIAN RESEARCH (2009)
Antitumor activity and biodistribution of cisplatin nanocapsules in nude mice bearing human ovarian carcinoma xenografts
Rutger W. H. M. Staffhorst et al.
ANTI-CANCER DRUGS (2008)
Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells
Zhengyu Li et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2008)
Suppression of human ovarian SKOV-3 cancer cell growth by Duchesnea phenolic fraction is associated with cell cycle arrest and apoptosis
Bo Peng et al.
GYNECOLOGIC ONCOLOGY (2008)
Hydrogels in drug delivery: Progress and challenges
Todd R. Hoare et al.
POLYMER (2008)
Nanoparticles for drug delivery in cancer treatment
Barbara Haley et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2008)
Preparation and evaluation of nanoparticles made of chitosan or N-trimethyl chitosan and a cisplatin-alginate complex
S. Cafaggi et al.
JOURNAL OF CONTROLLED RELEASE (2007)
Ginkgo biloba and ovarian cancer prevention:: Epidemiological and biological evidence
Bin Ye et al.
CANCER LETTERS (2007)
A meta-analysis of the efficacy of intraperitoneal cisplatin for the front-line treatment of ovarian cancer
L. M. Hess et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2007)
Preparation, characterization and in vitro cytotoxicity of paclitaxel-loaded sterically stabilized solid lipid nanoparticles
Mi-Kyung Lee et al.
BIOMATERIALS (2007)
Design of a bifunctional fusion protein for ovarian cancer drug delivery: Single-chain anti-CA125 core-streptavidin fusion protein
Welson Wen-Shang Wang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2007)
Intraperitoneal chemotherapy in the first-line treatment of women with stage III epithelial ovarian cancer - A systematic review with melaanalyses
Laurie Elit et al.
CANCER (2007)
Attaching folic acid on gold nanoparticles using noncovalent interaction via different polyethylene glycol backbones and targeting of cancer cells
Resham Bhattacharya et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2007)
Hypericin-loaded nanoparticles for the photodynamic treatment of ovarian cancer
Magali Zeisser-Labouebe et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2006)
Ovarian cancer
Nicoletta Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
The use of a tropism-modified measles virus in folate receptor-targeted virotherapy of ovarian cancer
Kosei Hasegawa et al.
CLINICAL CANCER RESEARCH (2006)
Polymer-drug conjugates: Progress in polymeric prodrugs
Jayant Khandare et al.
PROGRESS IN POLYMER SCIENCE (2006)
Anticancer efficacies of cisplatin-releasing pH-responsive nanoparticles
PS Xu et al.
BIOMACROMOLECULES (2006)
Antiproliferation and apoptosis induced by curcumin in human ovarian cancer cells
MX Shi et al.
CELL BIOLOGY INTERNATIONAL (2006)
Intraperitoneal cisplatin and paclitaxel in ovarian cancer
DK Armstrong et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Ifosfamide/mesna as salvage therapy in platinum pretreated ovarian cancer patients-long-term results of a Phase II study
M Baur et al.
CANCER INVESTIGATION (2006)
Docetaxel in ovarian cancer
PF Escobar et al.
EXPERT OPINION ON PHARMACOTHERAPY (2005)
Plants as a source of anti-cancer agents
GM Cragg et al.
JOURNAL OF ETHNOPHARMACOLOGY (2005)
Nanostructure-mediated drug delivery
Gareth A. Hughes
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2005)
Epithelial ovarian cancer: A review of current management
AE Guppy et al.
CLINICAL ONCOLOGY (2005)
Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma
MJ Turk et al.
CANCER LETTERS (2004)
Uptake of folate-conjugated albumin nanoparticles to the SKOV3 cells
LK Zhang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2004)
Oral altretamine used as salvage therapy in recurrent ovarian cancer
JK Chan et al.
GYNECOLOGIC ONCOLOGY (2004)
OVCAR-3 cells internalize TAT-peptide modified liposomes by endocytosis
MM Fretz et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
SS Dharap et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Gemcitabine as a single-agent treatment for ovarian cancer
WC Fowler et al.
GYNECOLOGIC ONCOLOGY (2003)
Aqueous extract of herba Scutellaria barbatae, a chinese herb used for ovarian cancer, induces apoptosis of ovarian cancer cell lines
CB Powell et al.
GYNECOLOGIC ONCOLOGY (2003)
Nanoparticles in cancer therapy and diagnosis
I Brigger et al.
ADVANCED DRUG DELIVERY REVIEWS (2002)
Share Paper
